The annual report details trends in workplace drug testing, as well as overall positivity rate across all industries in the United States.

The Quest DTI report is based on supplementary data of 10.6 million identified urine, hair and oral fluid drug test results conducted from January 1, 2022 through December 31, 2022. The 2021 and 2022 positivity rates were reported the highest rates since 2001, showing a 30% increase from the all-time low seen in 2010-2012.

Over a five year period, workforce positivity increased overall in every industry data released. Food Services topped the chart with a 42.9 % increase in positivity rate. Finance and Insurance saw an increase of 2.6% in 2018 versus 3.6 % in 2022, a 38.5% increase. The new peak follows a steady increase in post-accident marijuana positivity every year from 2012 to 2022. In that 10-year time frame, post-accident marijuana positivity increased 204.2%.

Marijuana, cocaine and amphetamines showed widespread increases across all sectors. Marijuana continues to be the number one drug for which donors test positive. Amphetamine positives increased by 15.4%. The continued rise in marijuana positives is seen in states that have legalized marijuana use, as well as states that have medical marijuana laws on the books.

Source: Quest Diagnostics Drug Testing Index Report 2023
Drug Testing Index Data Tables
Drug Testing Index Press Release

Posted: June 1, 2023

All Rights Reserved © 2023 Business Information Group, Inc.
This document and/or presentation is provided as a service to our customers. Its contents are designed solely for informational purposes, and should not be inferred or understood as legal advice or binding case law, nor shared with any third parties. Persons in need of legal assistance should seek the advice of competent legal counsel. Although care has been taken in preparation of these materials, we cannot guarantee the accuracy, currency or completeness of the information contained within it. Anyone using this information does so at his or her own risk.